Adagio Medical's ULTA Technology to Debut at Heart Rhythm Conference

The company's innovative catheter ablation system will be featured at the industry's premier event.

Apr. 16, 2026 at 6:42pm

An ethereal, X-ray-like image of a cardiac catheter device, its intricate internal structure visible in glowing, ghostly detail against a dark background, conceptually representing the advanced technology being unveiled at the industry conference.Adagio Medical's ULTA catheter ablation technology, showcased at the Heart Rhythm 2026 Conference, aims to revolutionize the treatment of complex cardiac arrhythmias.Laguna Hills Today

Adagio Medical Holdings, Inc., a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, announced that its ULTA technology will be showcased at the upcoming Heart Rhythm 2026 Conference. The ULTA system is a novel catheter ablation solution designed to improve outcomes for patients suffering from cardiac rhythm disorders.

Why it matters

As a major industry event, the Heart Rhythm Conference provides a high-profile platform for Adagio to debut its ULTA technology to key opinion leaders, clinicians, and potential partners. Adagio's innovative approach to catheter ablation has the potential to advance treatment options and improve quality of life for many patients with complex heart rhythm issues.

The details

Adagio's ULTA technology is a next-generation catheter ablation system that utilizes advanced energy delivery and mapping capabilities to precisely target and eliminate abnormal electrical pathways in the heart. The system is designed to enhance procedural efficiency, reduce complications, and improve long-term outcomes for patients undergoing catheter ablation.

  • The Heart Rhythm 2026 Conference is scheduled to take place from June 25-28, 2026.

The players

Adagio Medical Holdings, Inc.

A leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias.

Got photos? Submit your photos here. ›

What’s next

Adagio plans to showcase the ULTA technology and engage with industry experts and potential partners during the Heart Rhythm 2026 Conference to gather feedback and explore commercialization opportunities.

The takeaway

Adagio's participation in the prestigious Heart Rhythm Conference underscores the company's commitment to advancing cardiac care through innovative technologies like the ULTA system. This debut has the potential to drive further development and adoption of Adagio's solutions, ultimately benefiting patients with complex heart rhythm disorders.